Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ZLAB Zai Lab > Detailed Quotes

ZLAB Zai Lab

38.050
-0.790-2.03%
Close 09/28 16:00 ET
38.0500.0000.00%
Post Mkt Price 09/28 16:00 ET
High
39.250
Open
38.900
Turnover
13.33M
Low
36.240
Pre Close
38.840
Volume
348.00K
Market Cap
3.65B
P/E(TTM)
Loss
52wk High
107.980
Shares
96.05M
P/E(Static)
Loss
52wk Low
22.510
Float Cap
3.07B
Bid/Ask %
0.00%
Historical High
193.540
Shs Float
80.56M
Volume Ratio
0.50
Historical Low
14.290
Dividend TTM
--
Div Yield TTM
--
P/B
3.02
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.43%
Amplitude
7.75%
Avg Price
38.305
Lot Size
1
Float Cap
3.07B
Bid/Ask %
0.00%
Historical High
193.540
Shs Float
80.56M
Volume Ratio
0.50
Historical Low
14.290
Dividend TTM
--
P/B
3.02
Dividend LFY
--
Turnover Ratio
0.43%
Amplitude
7.75%
Avg Price
38.305
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.
CEO: Dr. Samantha Du
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...